Whole blood neutrophil chemiluminescence in children with diabetes depending on their clinical condition

Central-European Journal of Immunology

Volumn 37, Issue 4, 2012, Pages 345-349

  Kaczmarek, Magda ^a   Lewandowicz Uszyńska, Aleksandra ^a   Iwanicka, Zdzisława ^a   Jankowski, Adam ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Children; Clinical condition; Diabetes; Neutrophil chemiluminescence

Indexed keywords

OXIDE; ZYMOSAN;

ADOLESCENT; ADULT; ARTICLE; CELL METABOLISM; CELL STIMULATION; CHEMILUMINESCENCE ANALYZER; CHEMOLUMINESCENCE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRESCHOOL CHILD; SCHOOL CHILD;

EID: 84875132362     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: 10.5114/ceji.2012.32723     Document Type: Article

References (35)

1. Goh SY, Cooper ME (2008): The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 93: 1143-1152.
2. Nerup J, Mandrup-Poulsen T, Helqvist S, et al. (1994): On the pathogenesis of IDDM. Diabetologia 37: S82-S89.
3. Knip M, Siljander H (2008): Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 7: 550-557.
4. Kantárová D, Buc M, Stuchlíková M, et al. (2006): Etiopatho-genesis of autoimmune diabetes mellitus in human. A review. Centr Eur J Immunol 31: 102-110.
5. Kolb H, Kolb-Bachofen V (1992): Nitric oxide: a pathogenetic factor in autoimmunity. Immunol Today 13: 157-160.
6. Iwanicka Z, Lewandowicz-Uszyñska A, Głab E, Kotschy B (2006): Relationship between nitrogen oxide and the degree of metabolic control of diabetes mellitus type 1 in children and adolescents. Wiad Lek 59: 27-31.
7. Alba-Loureiro TC, Munhoz CD, Martins JO, et al. (2007): Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res 40: 1037-1044.
8. Komosiñska K, Olczyk K (1995): The role of free radicals in pathogenesis of insulin dependent diabetes mellitus. Postepy Hig Med Dosw 49: 733-746.
9. Mandrup-Poulsen T, Corbett JA, McDaniel ML, Nerup J (1993): What are types and cellular sources of free radicals in the pathogenesis of type1 (insulin-dependent) diabetes melli-tus? Diabetologia 36: 470-471.
10. Hatanaka E, Monteagudo PT, Marrocos MS, Campa A(2006): Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin Exp Immunol 146: 443-447.
11. Rabinovitch A, Suarez WL, Thomas PD, et al. (1992): Cyto-toxic effects of cytokines on rat islets: evidence for involvement of free radicals and lipid peroxidation. Diabetologia 35: 409-413.
12. Maritim AC, Sanders RA, Watkins JB 3rd (2003): Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17: 24-38.
13. Rabinovitch A, Sumoski W, Rajotte RV, Warnock GL (1990): Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab 71: 152-156.
14. Pinzani P, Petruzzi E, Orlando C, et al. (1998): Serum antiox-idant capacity in healthy and diabetic subjects as determined by enhanced chemiluminescence. J Biolumin Chemilumin 13: 321-325.
15. Terekhina NA, Khorobrykh OIu, Khorobrykh TP (1998): Antioxidant enzyme activity in the erythrocytes of rats with alloxan diabetes. Patol Fiziol Eksp Ter 4: 25-26.
16. Allen RC (1986): Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. Methods Enzymol 133: 449-493.
17. Lewandowicz-Uszyñska A, Jarguliñska-Forysiak E (2003): Application of neutrophils chemiluminescence test in medical diagnostics. Centr Eur J Immunol 28: 131-137.
18. Lewkowicz P, Lauk-Pachuła B, Górañska N, et al. (1999): The attempt of standardization of the whole blood chemilu-minescence assessment as a method of examining the human granulocytes' function in the "in vitro" research. Diagn Lab 35: 497-510.
19. Gil-del Valle L, de la C Milian L, Toledo A, et al. (2005): Altered redox status in patients with diabetes mellitus type I. Pharmacol Res 51: 375-380.
20. Telci A, Cakatay U, Salman S, et al. (2000): Oxidative protein damage in early stage type 1 diabetic patients. Diabetes Res Clin Pract 50: 213-223.
21. Zgliczyñski JM, Kwasnowska E, Stelmaszyñska T, et al. (1988): Functional states of neutrophils as suggested by whole blood chemiluminescence. Acta Biochim Pol 35: 331-342.
22. Paœnik J (1998): TNF-alpha preactivation (priming) of neu-trophils-effect on selected neutrophil functions. Post Hig Med Dosw 52: 139-155.
23. Favier A (2006): Oxidative stress in human diseases. Ann Pharm Fr 64: 390-396.
24. Valko M, Leibfritz D, Moncol J, et al. (2007): Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44-84.
25. Hunt JV, Dean RT, Wolff SP (1988): Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 256: 205-212.
26. Erciyas F, Taneli F, Arslan B, Uslu Y, et al. (2004): Glycemic control, oxidative stress, and lipid profile in children with type 1 diabetes mellitus. Arch Med Res 35: 134-140.
27. Lewandowicz-Uszyñska A, Jankowski A (2004): Chemilu-minescence of neutrophiles stimulated by opsonized Zymosan in children with asthma bronchiale and pneumonia. Proc SPIE 5566: 165-170.
28. Lewandowicz-Uszyñska A, Jankowski A(2001): Application of neutrofils chemiluminescence test in the differential diagnosis of asthma and rrti the remission period in children. Proc SPIE 91: 4515.
29. Zabuska-Jabłoñska K, Broniek A (1997): Disturbances of poly-morphonuclear neutrophil leukocyte chemiluminescence in patients with chronic or recurrent respiratory tract infections. Pneumonol Alergol Pol 65: 649-656.
30. Zozuliñska D, Wierusz-Wysocka B (2000): Wybrane mecha-nizmy patogenetyczne przewlekłych powikłañ cukrzycy. II. Rola granulocytów obojêtnochłonnych. Diabetol Pol 7: 198.
31. Gallacher SJ, Thomson G, Fraser WD, et al. (1995): Neu-trophils bactericidal function in diabetes mellitus: evidence for association with blood glucose control. Diabet Med 12: 916-920.
32. Oldenborg PA (1999): Effects of insulin on N-formyl-methionyl-leucyl- phenylalanine (fMet-Leu-Phe)-stimulated production of reactive oxygen metabolites from normal human neutrophils. Inflamm Res 48: 404-411.
33. Scatena R, Nocca G, De Sole P, et al. (1998): Impaired reactive oxygen metabolism of phagocytic leukocytes in NIDDM patients. A role for non-enzymatic glycosylation of collagen. J Biolumin Chemilumin 13: 273-278.
34. Saeed FA, Castle GE (1998): Neutrophil chemiluminescence during phagocytosis is inhibited by abnormally elevated levels of acetoacetate: implications for diabetic susceptibility to infections. Clin Diagn Lab Immunol 5: 740-743.
35. Delamaire M, Maugendre D, Moreno M, et al. (1997): Impaired leucocyte functions in diabetic patients. Diabet Med 14: 29-34.